Metabolic syndrome is associated with visit-to-visit systolic blood pressure variability in the US adults

Hypertension Research

Volumn 37, Issue 9, 2014, Pages 875-879

  Faramawi, Mohammed F ^a,b   Delongchamp, Robert ^a   Said, Qayyim ^c   Jadhav, Supriya ^a   Abouelenien, Saly ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b MENOUFIA UNIVERSITY   (Egypt)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE VARIABILITY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; ELEVATED BLOOD PRESSURE; FEMALE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; MALE; METABOLIC SYNDROME X; SYSTOLIC BLOOD PRESSURE; UNITED STATES; VISIT TO VISIT SYSTOLIC BLOOD PRESSURE VARIABILITY; WAIST CIRCUMFERENCE; BLOOD PRESSURE; HEALTH SURVEY; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADULT; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; FEMALE; HEALTH SURVEYS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; UNITED STATES;

EID: 84924748172     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2014.89     Document Type: Article

References (37)

1. Perkovic V, Huxley R, Wu Y, Prabhakaran D, MacMahon S. The burden of blood pressure-related disease: a neglected priority for global health. Hypertension 2007; 50: 991-997.
2. Moser M, Basile J, Cushman W. Hypertension, renal disease, and cardiovascular outcomes. J Clin Hypertens (Greenwich) 2005; 7: 479-484.
3. Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA 2010; 303: 2043-2050.
4. Grassi G, Bombelli M, Brambilla G, Trevano FQ, Delloro R, Mancia G. Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications. Curr Hypertens Rep 2012; 14: 333-338.
5. Rossignol P, Kessler M, Zannad F. Visit-to-visit blood pressure variability and risk for progression of cardiovascular and renal diseases. Curr Opin Nephrol Hypertens 2013; 22: 59-64.
6. Parati G, Ochoa JE, Lombardi C, Bilo G. Assessment and management of bloodpressure variability. Nat Rev Cardiol 2013; 10: 143-155.
7. Parati G, Ochoa JE, Salvi P, Lombardi C, Bilo G. Prognostic value of blood pressure variability and average blood pressure levels in patients with hypertension and diabetes. Diabetes Care 2013; 36(Suppl 2), S312-S324.
8. Rothwell PM, Howard SC, Dolan E, OBrien E, Dobson JE, Dahlof B, Sever PS, Poulter NR. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375: 895-905.
9. Batsis JA, Nieto-Martinez RE, Lopez-Jimenez F. Metabolic syndrome: from global epidemiology to individualized medicine. Clin Pharmacol Ther 2007; 82: 509-524.
10. McCullough AJ. Epidemiology of the metabolic syndrome in the USA. J Dig Dis 2011; 12: 333-340.
11. Zhao Z, Nie H, He H, Yan Z, Liu D, Luo Z, Ma L, Ni Y, Chen J, Jing J, Cao T, Yang H, Tepel M, Zhang W, Zhu Z. High-sensitivity C-reactive protein predicts target organ damage in Chinese patients with metabolic syndrome. Metabolism 2007; 56: 1612-1619.
12. McCullough AJ. Epidemiology of the metabolic syndrome in the USA. J Dig Dis 2011; 12: 333-340.
13. National Center for Health Statistics. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: Programs and collection procedures. Vital Health Stat 1994; 1: 1-407.
14. Grundy SM, Brewer HB Jr., Cleeman JI, Smith SC Jr., Lenfant C, National Heart L, Blood IAmerican Heart A. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol 2004; 24: e13-e18.
15. Benowitz NL, Bernert JT, Caraballo RS, Holiday DB, Wang J. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ ethnic groups in the United States Between 1999 and 2004. Am J Epidemiol 2009; 169: 236-248.
16. Koumaras C, Katsiki N, Athyros VG, Karagiannis A. Metabolic syndrome and arterial stiffness: the past, the present and the future. J Cardiovasc Med (Hagerstown) 2013; 14: 687-689.
17. Weiss TW, Arnesen H, Seljeflot I. Components of the interleukin-6 transsignalling system are associated with the metabolic syndrome, endothelial dysfunction and arterial stiffness. Metabolism 2013; 62: 1008-1013.
18. Li CI, Kardia SL, Liu CS, Lin WY, Lin CH, Lee YD, Sung FC, Li TC, Lin CC. Metabolic syndrome is associated with change in subclinical arterial stiffness: a communitybased Taichung community health study. BMC Public Health 2011; 11: 808.
19. Kim OY, Lim HH, Lee MJ, Kim JY, Lee JH. Association of fatty acid composition in serum phospholipids with metabolic syndrome and arterial stiffness. Nutr Metab Cardiovasc Dis 2013; 23: 366-374.
20. Oh EG, Kim SH, Bang SY, Hyun SS, Im JA, Lee JE, Yoo JY. High-sensitivity C-reactive protein is independently associated with arterial stiffness in women with metabolic syndrome. J Cardiovasc Nurs 2012; 27: 61-67.
21. Koivistoinen T, Hutri-Kahonen N, Juonala M, Aatola H, Koobi T, Lehtimaki T, Viikari JS, Raitakari OT, Kahonen M. Metabolic syndrome in childhood and increased arterial stiffness in adulthood: the Cardiovascular Risk In Young Finns Study. Ann Med 2011; 43: 312-319.
22. Troseid M, Seljeflot I, Weiss TW, Klemsdal TO, Hjerkinn EM, Arnesen H. Arterial stiffness is independently associated with interleukin-18 and components of the metabolic syndrome. Atherosclerosis 2010; 209: 337-339.
23. Achimastos AD, Efstathiou SP, Christoforatos T, Panagiotou TN, Stergiou GS, Mountokalakis TD. Arterial stiffness: determinants and relationship to the metabolic syndrome. Angiology 2007; 58: 11-20.
24. Sipila K, Koivistoinen T, Moilanen L, Nieminen T, Reunanen A, Jula A, Salomaa V, Kaaja R, Koobi T, Kukkonen-Harjula K, Majahalme S, Kahonen M. Metabolic syndrome and arterial stiffness: the Health 2000 Survey. Metabolism 2007; 56: 320-326.
25. Nestel P. Relationship between arterial stiffness and glucose metabolism in women with metabolic syndrome. Clin Exp Pharmacol Physiol 2006; 33: 883-886.
26. Tomiyama H, Koji Y, Yambe M, Motobe K, Shiina K, Gulnisa Z, Yamamoto Y, Yamashina A. Elevated C-reactive protein augments increased arterial stiffness in subjects with the metabolic syndrome. Hypertension 2005; 45: 997-1003.
27. van den Bogaard B, Westerhof BE, van den Born B-JH. Prognostic significance of blood-pressure variability. Lancet 2010; 376: 413.
28. Diaz KM, Veerabhadrappa P, Kashem MA, Feairheller DL, Sturgeon KM, Williamson ST, Crabbe DL, Brown MD. Relationship of visit-to-visit and ambulatory blood pressure variability to vascular function in African Americans. Hypertens Res 2012; 35: 55-61.
29. Lind L, Berglund L, Larsson A, Sundstrom J. Endothelial function in resistance and conduit arteries and 5-year risk of cardiovascular disease. Circulation 2011; 123: 1545-1551.
30. Mancia G, Ferrari A, Gregorini L, Parati G, Pomidossi G, Bertinieri G, Grassi G, di Rienzo M, Pedotti A, Zanchetti A. Blood pressure and heart rate variabilities in normotensive and hypertensive human beings. Circ Res 1983; 53: 96-104.
31. Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 2004; 19: 357-362.
32. Muntner P, Levitan EB, Joyce C, Holt E, Mann D, Oparil S, Krousel-Wood M. Association between antihypertensive medication adherence and visit-to-visit variability of blood pressure. J Clin Hypertens (Greenwich) 2013; 15: 112-117.
33. Levitan EB, Kaciroti N, Oparil S, Julius S, Muntner P. Relationships between metrics of visit-to-visit variability of blood pressure. J Hum Hypertens 2013; 27: 589-593.
34. Faramawi MF, Sall M, Abdul Kareem MY. The association of the metabolic syndrome with T-wave axis deviation in NHANES III. Ann Epidemiol 2008; 18: 702-707.
35. Faramawi MF, Wildman RP, Gustat J, Rice J, Abdul Kareem MY. The association of the metabolic syndrome with QTc interval in NHANES III. Eur J Epidemiol 2008; 23: 459-465.
36. Ford ES, Kohl HW 3rd, Mokdad AH, Ajani UA. Sedentary behavior, physical activity, and the metabolic syndrome among US adults. Obes Res 2005; 13: 608-614.
37. Skirton H, Chamberlain W, Lawson C, Ryan H, Young E. A systematic review of variability and reliability of manual and automated blood pressure readings. J Clin Nurs 2011; 20: 602-614.